Suhayl Dhib-Jalbut is a Professor and the Chairman of the Department of Neurology at The UMDNJ-Robert Wood Johnson Medical School and the Chief of the Neurology Service at the Robert Wood Johnson University Hospital. He is also the Director of the Robert Wood Johnson Center for Multiple Sclerosis. Dr. Dhib-Jalbut graduated Alpha Omega Alpha from the American University of Beirut in Lebanon and completed his neurology training at the University of Cincinnati in Ohio. He then joined the National Institutes of Health in Bethesda, Md, where he specialized in multiple sclerosis and neuroimmunology between 1985 and 1990. Dr. Dhib-Jalbut joined the faculty of the University of Maryland in Baltimore in July 1990 where he established a research program in multiple sclerosis, contributed to clinical research that led to the approval of the current MS therapies, and conducted basic research on how these therapies alter the immune system. He was recruited to UMDNJ-Robert Wood Johnson Medical School in 2003 as a Professor and the Chairman of the Department of Neurology. Dr. Dhib-Jalbut published over 100 manuscripts in the scientific literature and is an Associate Editor for the Journal of Neuroimmunology. Moreover, he served on several national and international scientific committees including Chairmanship of the Scientific Committee for the World Congress on Multiple Sclerosis that was held in Montreal in September 2008. Dr. Dhib-Jalbut received several awards and recognitions. Most recently, he was named by peers among The Best Doctors in America, was awarded the Norman H. Edelman Clinical Science Mentoring Award at UMDNJ, and was presented with the National Multiple Sclerosis Society-New Jersey Metro Chapter Medical Excellence Award. His current research interests include how MS therapies work, development of biomarkers that predict response to MS therapies, and neuroprotective gene therapy in animal models of multiple sclerosis.
Biography Updated on 6 December 2009